The Christie at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

The Christie takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer, from choosing maintenance therapy in extensive-stage small cell lung cancer to engineered cell therapies. It also looks at the biology of metastasis and how cancer spread can be targeted.

OrganizationESMO 2026 Attendance
The Christie
Manchester, United Kingdom
christie.nhs.uk
Cancer centre & hospital
Specialist cancer hospital and NHS foundation trust in Manchester, United Kingdom.
Chair
Sat Oct 24
08:30–10:00
Metastases: Understanding and targeting cancer spread
with Vall d'Hebron Institute of Oncology (VHIO)
Biomarkers & precision oncology
Satellite
Sat Oct 24
19:05–19:25
The value of time leading the choice of maintenance therapy
PharmaMar - More time for patients: Reframing the course of ES-SCLC
Lung & thoracic cancers
Talk
Sun Oct 25
14:45–15:05
Perspectives in cellular engineering for lung cancer
Coming soon to your clinic? New therapies and approaches for lung cancer
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from The Christie

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction